Cargando…

Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement

ABSTRACT: Langerhans cell sarcoma (LCS) typically presents as cytologic atypia and clinical aggressiveness and may involve multiple organs during the progression of the disease. Primary skin LCS without any extra-cutaneous site association is extremely rare and only a few such cases have been descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Li, Bin, Tian, Xiao-ying, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570402/
https://www.ncbi.nlm.nih.gov/pubmed/23388086
http://dx.doi.org/10.1186/1746-1596-8-20
_version_ 1782259066246004736
author Li, Yang
Li, Bin
Tian, Xiao-ying
Li, Zhi
author_facet Li, Yang
Li, Bin
Tian, Xiao-ying
Li, Zhi
author_sort Li, Yang
collection PubMed
description ABSTRACT: Langerhans cell sarcoma (LCS) typically presents as cytologic atypia and clinical aggressiveness and may involve multiple organs during the progression of the disease. Primary skin LCS without any extra-cutaneous site association is extremely rare and only a few such cases have been described in the literature. We present a case of unusual primary LCS in skin occurring in a middle-aged male patient. Physical examination revealed a large ulcerated cutaneous lesion and a smaller nodular lesion were located in the skin of the extensor side of his right knee. There was no regional lymph node or any other extra-cutaneous organ involvement. Histologically, typical large and pleomorphological tumor cells with epithelioid appearance and significantly malignant cytological features were observed to infiltrate in dermis and subcutaneous tissue. By immunohistochemistry, the tumor cells were positive for CD1a, S-100 protein and largerin strongly and diffusely. However, these cells were negative for CD3, CD20, CD21, pan-cytokeratin, HMB-45, Melan-A, and MPO. A diagnosis of primary cutaneous LCS was made. The patient received systemic chemotherapy of CHOP regimen, and was on a regular follow-up period for 12 months. There was no sign of relapse of tumor or any other extra-cutaneous organ involvement by whole body positron emission tomography/computed tomography (PET/CT) study. Because LCS is a high-grade malignancy with poor prognosis, it suggests that strict histological analysis and thorough radiographic examination are necessary for accurately diagnosing this tumor even if cutaneous involvement presented only. VIRTUAL SLIDES: http://www.diagnosticpathology.diagnomx.eu/vs/6527428618381393
format Online
Article
Text
id pubmed-3570402
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35704022013-02-13 Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement Li, Yang Li, Bin Tian, Xiao-ying Li, Zhi Diagn Pathol Case Report ABSTRACT: Langerhans cell sarcoma (LCS) typically presents as cytologic atypia and clinical aggressiveness and may involve multiple organs during the progression of the disease. Primary skin LCS without any extra-cutaneous site association is extremely rare and only a few such cases have been described in the literature. We present a case of unusual primary LCS in skin occurring in a middle-aged male patient. Physical examination revealed a large ulcerated cutaneous lesion and a smaller nodular lesion were located in the skin of the extensor side of his right knee. There was no regional lymph node or any other extra-cutaneous organ involvement. Histologically, typical large and pleomorphological tumor cells with epithelioid appearance and significantly malignant cytological features were observed to infiltrate in dermis and subcutaneous tissue. By immunohistochemistry, the tumor cells were positive for CD1a, S-100 protein and largerin strongly and diffusely. However, these cells were negative for CD3, CD20, CD21, pan-cytokeratin, HMB-45, Melan-A, and MPO. A diagnosis of primary cutaneous LCS was made. The patient received systemic chemotherapy of CHOP regimen, and was on a regular follow-up period for 12 months. There was no sign of relapse of tumor or any other extra-cutaneous organ involvement by whole body positron emission tomography/computed tomography (PET/CT) study. Because LCS is a high-grade malignancy with poor prognosis, it suggests that strict histological analysis and thorough radiographic examination are necessary for accurately diagnosing this tumor even if cutaneous involvement presented only. VIRTUAL SLIDES: http://www.diagnosticpathology.diagnomx.eu/vs/6527428618381393 BioMed Central 2013-02-06 /pmc/articles/PMC3570402/ /pubmed/23388086 http://dx.doi.org/10.1186/1746-1596-8-20 Text en Copyright ©2013 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Li, Yang
Li, Bin
Tian, Xiao-ying
Li, Zhi
Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title_full Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title_fullStr Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title_full_unstemmed Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title_short Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement
title_sort unusual cutaneous langerhans cell sarcoma without extracutaneous involvement
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570402/
https://www.ncbi.nlm.nih.gov/pubmed/23388086
http://dx.doi.org/10.1186/1746-1596-8-20
work_keys_str_mv AT liyang unusualcutaneouslangerhanscellsarcomawithoutextracutaneousinvolvement
AT libin unusualcutaneouslangerhanscellsarcomawithoutextracutaneousinvolvement
AT tianxiaoying unusualcutaneouslangerhanscellsarcomawithoutextracutaneousinvolvement
AT lizhi unusualcutaneouslangerhanscellsarcomawithoutextracutaneousinvolvement